PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-9.37%
Both yoy net incomes decline, with VUZI at -75.02%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
12.89%
D&A growth well above VUZI's 22.12%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-4.93%
Negative yoy deferred tax while VUZI stands at 73.75%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
4.93%
SBC growth while VUZI is negative at -12.11%. John Neff would see competitor possibly controlling share issuance more tightly.
-1.56%
Negative yoy working capital usage while VUZI is 7.09%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
341.78%
AR growth well above VUZI's 245.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
175.61%
Inventory growth well above VUZI's 224.83%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-95.90%
Both negative yoy AP, with VUZI at -75.39%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-34.60%
Both reduce yoy usage, with VUZI at -303.36%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
No Data
No Data available this quarter, please select a different quarter.
-6.11%
Both yoy CFO lines are negative, with VUZI at -78.02%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-375.16%
Both yoy lines negative, with VUZI at -15.86%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
17.31%
Purchases growth of 17.31% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
2.00%
Liquidation growth of 2.00% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-1431.82%
We reduce yoy other investing while VUZI is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
12.61%
We have mild expansions while VUZI is negative at -15.86%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
206.02%
Issuance growth of 206.02% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.